AIM2 DISCOVERY CENTER
"AIM2 DISCOVERY CENTER" is a figurative mark owned by Pfizer Inc., filed at the USPTO on April 23, 2026. It is in its opposition period and covers class 42 (Computer and Scientific Services).
- Status
- Opposition period
- Since September 29, 2026
- Filed
- April 23, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99782654
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 1 class
Who owns AIM2 DISCOVERY CENTER
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Pfizer Inc.
PFE · New York, United States
Representative
Andrea Christensen
Pfizer Inc.
What the mark covers
The products and services AIM2 DISCOVERY CENTER is filed for, grouped by Nice class.
Pharmaceutical research and development; Medical and scientific research in the field of cardiometabolic disease using artificial intelligence
What has happened so far
Steps recorded by the USPTO, newest first.
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Notification of examiners amendment e-mailed
- Examiner's amendment entered
- Examiners amendment e-mailed
- Examiners amendment -written
- Notification of non-final action e-mailed
- Non-final action e-mailed
5 earlier steps on the official record.
About AIM2 DISCOVERY CENTER
Who owns the trademark "AIM2 DISCOVERY CENTER"?
The USPTO trademark "AIM2 DISCOVERY CENTER" (application 99782654) is owned by Pfizer Inc.
What is the status of "AIM2 DISCOVERY CENTER"?
Its status at the USPTO is: opposition period.
Get this data via the API
Everything on this page comes from the Signa API. Pull AIM2 DISCOVERY CENTER and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019dc764-6f5a-734c-81c5-1fbc52b11fea
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019dc764-6f5a-734c-81c5-1fbc52b11fea",
"object": "trademark",
"mark_text": "AIM2 DISCOVERY CENTER",
"status": {
"primary": "pending",
"stage": "pending_opposition"
},
"office_code": "US",
"application_number": "99782654",
"filing_date": "2026-04-23",
"nice_classes": [
42
],
"owners": [
{
"name": "Pfizer Inc.",
"entity_id": "ent_019f2853-15ff-713b-878b-ed770179b310"
}
]
}